Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers.
Not Applicable
- Conditions
- Hereditary Breast and Ovarian Cancer
- Registration Number
- JPRN-UMIN000027999
- Lead Sponsor
- agoya university faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Female has active invasive cancer. Female with mental disabilities and who has difficulty to make a determination of therapy. Female during pregnancy and lactation. Femele with active infectional disease. Female who a doctor consider inappropriate Female under 20 years old
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main outcome measure is the complication rate at 4 to 6 days and at 5 weeks after surgery, as indicator of safety of the surgical procedure.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are to evaluate the appearance of menopausal symptoms rate before the surgery and at 6 and 24 months after the surgery